318 related articles for article (PubMed ID: 15542037)
21. Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system.
Dong J; Hunter E
Virology; 1993 May; 194(1):192-9. PubMed ID: 8386872
[TBL] [Abstract][Full Text] [Related]
22. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH
Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717
[TBL] [Abstract][Full Text] [Related]
24. Preparation and quantification of pseudotyped retroviral vector.
Yu H; Kwon YJ
Methods Mol Biol; 2008; 433():1-16. PubMed ID: 18679614
[TBL] [Abstract][Full Text] [Related]
25. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
26. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
27. Osteoclasts direct bystander killing of cancer cells in vitro.
Ramnaraine M; Pan W; Clohisy DR
Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
[TBL] [Abstract][Full Text] [Related]
28. Analysis of ALV-based packaging cell lines for production of contaminant defective viruses.
Girod A; Cosset FL; Verdier G; Ronfort C
Virology; 1995 Jun; 209(2):671-5. PubMed ID: 7778301
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
30. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
[TBL] [Abstract][Full Text] [Related]
31. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
[TBL] [Abstract][Full Text] [Related]
33. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
34. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
35. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O
Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
[TBL] [Abstract][Full Text] [Related]
36. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.
von Rüden T; Stingl L; Cotten M; Wagner E; Zatloukal K
Biotechniques; 1995 Mar; 18(3):484-9. PubMed ID: 7779400
[TBL] [Abstract][Full Text] [Related]
37. Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor.
Camper N; Byrne T; Burden RE; Lowry J; Gray B; Johnston JA; Migaud ME; Olwill SA; Buick RJ; Scott CJ
J Immunol Methods; 2011 Sep; 372(1-2):30-41. PubMed ID: 21782818
[TBL] [Abstract][Full Text] [Related]
38. Adeno-retroviral chimeric viruses as in vivo transducing agents.
Caplen NJ; Higginbotham JN; Scheel JR; Vahanian N; Yoshida Y; Hamada H; Blaese RM; Ramsey WJ
Gene Ther; 1999 Mar; 6(3):454-9. PubMed ID: 10435096
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene.
Kobinger GP; Mouland AJ; Lalonde JP; Forget J; Cohen EA
Gene Ther; 1997 Aug; 4(8):868-74. PubMed ID: 9338017
[TBL] [Abstract][Full Text] [Related]
40. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
